| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998477 | Anti-CD19 Reference Antibody (denintuzumab), Anti-CD19 Reference Antibody (denintuzumab), |
|||
| A998478 | Anti-CD19 Reference Antibody (Duke U. patent anti-CD19), Anti-CD19 Reference Antibody (Duke U. patent anti-CD19), |
|||
| A998479 | Anti-CD19 Reference Antibody (Immunomedics hA19), Anti-CD19 Reference Antibody (Immunomedics hA19), |
|||
| A998480 | Anti-CD19 Reference Antibody (inebilizumab), Anti-CD19 Reference Antibody (inebilizumab), |
|||
| A998481 | Anti-CD19 Reference Antibody (obexelimab), Anti-CD19 Reference Antibody (obexelimab), |
|||
| A998482 | Anti-CD19 Reference Antibody (tafasitamab), Anti-CD19 Reference Antibody (tafasitamab), |
|||
| A998483 | Anti-CD2 Reference Antibody (siplizumab), Anti-CD2 Reference Antibody (siplizumab), |
|||
| A998484 | Anti-CD20 Reference Antibody (divozilimab), Anti-CD20 Reference Antibody (divozilimab), |
|||
| A998485 | Anti-CD20 Reference Antibody (ibritumomab), Anti-CD20 Reference Antibody (ibritumomab), |
|||
| A998486 | Anti-CD20 Reference Antibody (obinutuzumab), Anti-CD20 Reference Antibody (obinutuzumab), |
|||
| A998487 | Anti-CD20 Reference Antibody (ocaratuzumab), Anti-CD20 Reference Antibody (ocaratuzumab), |
|||
| A998488 | Anti-CD20 Reference Antibody (ocrelizumab), Anti-CD20 Reference Antibody (ocrelizumab), |
|||
| A998489 | Anti-CD20 Reference Antibody (ofatumumab), Anti-CD20 Reference Antibody (ofatumumab), |
|||
| A998490 | Anti-CD20 Reference Antibody (Regeneron patent anti-CD20), Anti-CD20 Reference Antibody (Regeneron patent anti-CD20), |
|||
| A998491 | Anti-CD20 Reference Antibody (ripertamab), Anti-CD20 Reference Antibody (ripertamab), |
|||
| A998492 | Anti-CD20 Reference Antibody (rituximab), Anti-CD20 Reference Antibody (rituximab), |
|||
| A998493 | Anti-CD20 Reference Antibody (TRU-015), Anti-CD20 Reference Antibody (TRU-015), |
|||
| A998494 | Anti-CD20 Reference Antibody (ublituximab), Anti-CD20 Reference Antibody (ublituximab), |
|||
| A998495 | Anti-CD20 Reference Antibody (veltuzumab), Anti-CD20 Reference Antibody (veltuzumab), |
|||
| A998496 | Anti-CD20 Reference Antibody (zuberitamab), Anti-CD20 Reference Antibody (zuberitamab), |